Published date: 26 September 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Research and development services and related consultancy services - 73000000
Evaluation consultancy services - 79419000
Location of contract
United Kingdom
Value of contract
£0
Procurement reference
AHSN001-DN736345-50190401
Published date
26 September 2024
Closing date
4 September 2024
Closing time
11:59pm
Contract start date
30 September 2024
Contract end date
31 March 2025
Contract type
Service contract
Procedure type
Restricted procedure
A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Funding was received by Health Innovation North East and North Cumbria (HI NENC) in April 2021 to implement and lead on the national Child Parent Screening Programme. This was in order to support the ambition set out in the NHS Long Term Plan to improve the identification of Familial Hypercholesterolaemia (FH) to 25% by 2025.
Previously, HI NENC had embarked on a programme of work to search primary care records for those at risk of FH. Alone this was unlikely to achieve the NHS LTP ambition - the addition of a child-parent screening (CPS) programme was introduced to help increase identification of FH patients and their families.
FH, an autosomal dominant inherited disorder, is a common cause of ischaemic cardiovascular disease in young adult life. There are about 200,000 undiagnosed people with FH in the UK. Identifying affected individuals before the onset of disease is important so diet and lifestyle modifications can be made and medication initiated as appropriate.
As each affected child will have one affected parent, testing children provides a means of identifying and treating both child and parent together in a systematic manner.
This project aims to evaluate the effectiveness of the implementation of the child parent screening service as well as the impact it has had. A mixed methods approach will be used drawing on a variety of techniques.
Award information
Awarded date
24 September 2024
Contract start date
30 September 2024
Contract end date
31 March 2025
Total value of contract
£39,850
This contract was awarded to 1 supplier.
Unity Insights Limited
Address
Amelia House, Crescent Road, Worthing, East Sussex, BN11 1RL, United Kingdom
Reference
None
Supplier is SME?
Yes
Supplier is VCSE?
No
About the buyer
Address
Suite A, 2nd Floor, 1 Citygate
Gallowgate
Newcastle-upon-Tyne
NE1 4WH
England
Telephone
+44 1916076350
BusinessDevelopment@healthinnovationnenc.org.uk
Website
Share this notice
Closing: 4 September 2024, 11:59pm